Arca
Skip to content
Tools
Tools

Core-Injector

Endoscopic Injection Needle, Gastroenterology-Urology. 510(k) K221054, from Incore Co., Ltd. (Daegu, KR). Product code FBK, class 2.

As of Nov 18, 2026, K221054 is an FDA 510(k) held by Incore Co., Ltd., substantially equivalent on Dec 21, 2022 after 254 days, with no recalls tied to it in FDA's recall database.

  • Review time: 254 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The CORE-INJECTOR is to be used in conjunction with an endoscope to perform endoscopic injections, such as the treatment of esophageal and gastric varices and for submucosal dye marking in the GI tract.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other FBK clearances

The newest 510(k)s for the same product code; their median review was 155 days; see every FBK device

Record

Type
Traditional
Received
Apr 11, 2022
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.1500

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.